Alteration of DNMT1/DNMT3A by eribulin elicits global DNA methylation changes with potential therapeutic implications for triple-negative breast cancer.

Bagheri, Meisam; Lee, Min Kyung; Muller, Kristen E; Miller, Todd W; Pattabiraman, Diwakar R; Christensen, Brock C

Bagheri, Meisam; Lee, Min Kyung; Muller, Kristen E; Miller, Todd W; Pattabiraman, Diwakar R; Christensen, Brock C.

Afiliación

Bagheri M; Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Lebanon, NH 03766.
Lee MK; Dartmouth Cancer Center, Lebanon, NH, 03756.
Muller KE; Department of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, NH, 03756.
Miller TW; Dartmouth Cancer Center, Lebanon, NH, 03756.
Pattabiraman DR; Department of Pathology, Dartmouth-Hitchcock Medical Center, Lebanon NH 03756, USA.
Christensen BC; Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Lebanon, NH 03766.

bioRxiv ; 2023 Jun 10.

Article en En | MEDLINE | ID: mdl-37333096

Palabras clave

DNA methylation; DNMT1/DNMT3A; Epithelial-to-mesenchymal transition; mesenchymal-to-epithelial transition

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: BioRxiv Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google